Cornea News

Now in its 21st year, the Cornea Classic has cumululatively raised over $750,000 to fund new treatment options for those with complex vision problems. This year, join us either in-person or in spirit to help raise $50,000!

More than 40 percent of eye injuries that occur every year are related to sports or recreational activities. A recent study found that about 30,000 people in the U.S. went to an emergency department with a sports-related eye injury, a substantially higher estimate than previously reported.[i] Three sports accounted for almost half of all injuries: basketball, baseball and air/paintball guns.

On-the-job safety goes well beyond avoiding slips, falls, and heavy lifting. Caring for your eyes should be a high priority and part of an overall workplace wellness routine. Each day, about 2,000 U.S. workers sustain a job-related eye injury that requires medical treatment[1]. However, 90 percent of these accidents can be avoided by wearing eye protection[2]. As part of an ongoing effort to stress the importance of workplace eye wellness, the Cornea Research Foundation of America and the American Academy of Ophthalmology, during the month of March, is encouraging the public to do right by their eyes and wear appropriate eye protection.

Dr. Francis Price discusses advantages of formulas and add-ons that help in preoperative biometry with the LENSTAR for cataract surgery to optimize vision at the Hawaiian Eye Meeting In Maui, HI on January 17, 2018.

Bosma Enterprises, an Indianapolis-based nonprofit organization dedicated to creating opportunities for Hoosiers who are blind or visually impaired, is set to honor Dr. Francis Price at its annual Hasbrook Awards Luncheon at The Crane Bay in Indianapolis.

Interest is now building to eliminate transplants altogether and allow a person's own endothelial cells to regenerate in a procedure called Descemet's Stripping without Endothelial Replacement. This article, written by Dr. Francis Price and Dr. Matthew Feng share their results on this newer procedure.

The Cornea Research Foundation of America is pleased to announce a new investigational study, “The ROCK Inhibitor Study to Reduce Cornea Transplant Complications”. This study will enroll patients with Fuchs’ dystrophy or other forms of corneal endothelial failure who are undergoing a DMEK cornea transplant with Price Vision Group. The study aligns with the Foundation’s pioneering series of studies that began in 2011 to reduce side effects of corticosteroid eye drops to protect transplant health.

New research shows DMEK cornea transplant recipients do not need to adjust corticosteriod dosing prior to or after influenza vaccine. Read this article for up-to-date information regarding steroid use and vaccines with DMEK.